Stay updated on Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page
- Check7 days agoChange DetectedUpdated the page revision from v3.5.3 to v3.5.4, indicating a minor update to the site's versioning or content-management state. No study details or user-facing content were changed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the study details.SummaryDifference0.1%

- Check36 days agoChange DetectedThe revision label on the page was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded a new entry for Thyroid gland undifferentiated (anaplastic) carcinoma and a Genetic and Rare Diseases Information Center resources reference.SummaryDifference0.2%

- Check64 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0 (v3.5.0 added, v3.4.3 removed).SummaryDifference0.1%

- Check71 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.